The More, the Better? Predicting Prognosis in Primary Biliary Cholangitis

참고문헌 (12)

1. Kim KA, "Populationbased epidemiology of primary biliary cirrhosis in South Korea", Aliment Pharmacol Ther, 43, pp.154~162 (2016)
2. Zhang LN, "Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study", Hepatology, 58, pp.264~272 (2013)
3. Parés A, "Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid", Gastroenterology, 130, pp.715~720 (2006)
4. Corpechot C, "Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis", Hepatology, 48, pp.871~877 (2008)
5. Corpechot C, "Early primary biliary cirrhosis: biochemical response to treatment and prediction of longterm outcome", J Hepatol, 55, pp.1361~1367 (2011)
6. Kuiper EM, "Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid", Gastroenterology, 136, pp.1281~1287 (2009)
7. Lammers WJ, "Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy", Gastroenterology, 149, pp.1804~1812.e4 (2015)
8. Carbone M, "The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis", Hepatology, 63, pp.930~950 (2016)
9. Jeong-Ju Yoo, "Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio", Gut and Liver, 12(6), pp.714~721 (2018), 거트앤리버 소화기연관학회협의회
10. Yang F, "The risk predictive values of UKPBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210", Aliment Pharmacol Ther, 45, pp.733~743 (2017)
11. Imtiaz F, "Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population", Int Arch Med, 5, pp.2~ (2012)
12. Martin HL, "Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer", Intern Med J, 44, pp.676~682 (2014)